CTNNB1 mutations and β-catenin expression in endometrial carcinomas

Human Pathology

Volumn 33, Issue 2, 2002, Pages 206-212

  Machin, Pilar ^a   Catasus, Lluis ^a   Pons, Cristina ^a   Muñoz, Josefina ^a   Matias Guiu, Xavier ^a   Prat, Jaime ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

CTNNB1; Cyclin D1; Endometrial adenocarcinoma; Gene mutations; Immunohistochemistry; Matrix metalloproteinase 7; Microsatellite instability; Tumor progression; catenin

Indexed keywords

BETA CATENIN; CYCLIN D1; MATRILYSIN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA SEQUENCE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; EXON; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0036219634     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.30723     Document Type: Article

References (41)

1. Signal transduction through beta-catenin and specification of cell fate during embryogenesis
2. The interactions of APC, E-cadherin and beta-catenin in tumour development and progression
3. Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca pathways
4. Association of the APC gene product with beta-catenin
5. Association of the APC tumor suppressor protein with catenins
6. Binding of GSK3 beta to the APC-beta catenin complex and regulation of complex assembly
7. Activation of betacatenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
8. Stabilization of beta-catenin by genetic defects in melanoma cell lines
9. Mutations in the beta-catenin gene (CTNNB 1) in endometrioid ovarian carcinomas
10. Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer
11. The cyclin D1 gene is target of the beta-catenin/LEF-1 pathway
12. Beta-catenin mutations in carcinoma of the uterine endometrium
13. Mutations of the beta-catenin gene in endometrial carcinomas
14. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway
15. Mutational analysis of the CTNNB 1 and APC genes in uterine endometrioid carcinoma
16. Microsatellite instability in endometrial carcinoma
17. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma
18. Microsatellite instability in sporadic endometrial carcinoma
19. Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas
20. Microsatellite instability in endometrial carcinomas: Frequent replication errors in tumors of early onset and/or of poorly differentiated type
21. Mutational analysis of MSH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers
22. Genetic instability of microsatellites in endometrial carcinoma
23. Microsatellite instability in endometrial carcinomas. Clinicopathologic correlations in a series of 42 cases
24. Mutations in PTEN are frequent in endometrial carcinomas but rare in other common gynecological malignancies
25. PTEN 1 is frequently mutated in primary endometrial carcinomas
26. PTEN/MMAC 1 mutations in endometrial cancers
27. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics
28. hMLH-1 promoter hypermethylation is an early event in human endometrial tumorigenesis
29. PTEN mutations in endometrial carcinomas. A molecular and clinicopathologic analysis of 38 cases
30. K-RAS mutations in endometrial carcinomas with microsatellite instability
31. BAX somatic frameshift mutations in endometrioid adenocarcinomas of the endometrium: Evidence for a tumor progression role in endometrial carcinomas with microsatellite instability
32. Frameshift mutations at coding mononucleotide repeat microsatellites in endometrial carcinomas with microsatellite instability
33. Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas
34. Two pathogenetic types of endometrial carcinoma
35. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses
36. p53 in endometrial cancer and its putative precursors: Evidence for diverse pathways of tumorigenesis
37. p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis
38. Loss of heterozygosity in usual and special variant carcinomas of the endometrium
39. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
40. Correspondence to the National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
41. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein